This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Phase II Study of MEDI4736 Monotherapy in the Trea...
Clinical trial

Phase II Study of MEDI4736 Monotherapy in the Treatment of Patients With Recurrent or Metastatic SCCHN.

Read time: 1 mins
Last updated:1st Aug 2014

Primary Objective: To assess the efficacy of MEDI4736 monotherapy in terms of ORR

Category Value
Study start date 2014-08-01

View full details